Rare Disease

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making